Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases
AIM: To assess if software assisted-contrast-enhanced ultrasonography (CEUS) provides reproducible perfu- sion parameters of hepatic parenchyma in patients af- fected by chronic liver disease. METHODS: Forty patients with chronic viral liver dis- ease, with (n = 20) or without (n = 20) cirrhosis, an...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 18; no. 37; pp. 5225 - 5230 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Co., Limited
07.10.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | AIM: To assess if software assisted-contrast-enhanced ultrasonography (CEUS) provides reproducible perfu- sion parameters of hepatic parenchyma in patients af- fected by chronic liver disease. METHODS: Forty patients with chronic viral liver dis- ease, with (n = 20) or without (n = 20) cirrhosis, and 10 healthy subjects underwent CEUS and video re- cordings of each examination were then analysed with Esaote's Qontrast software. CEUS dedicated software Qontrast was used to determine peak (the maximum signal intensity), time to peak (TTP), region of blood value (RBV) proportional to the area under the time- intensity curve, mean transit time (MTT) measured in seconds and region of blood flow (RBF). RESULTS: Qontrast-assisted CEUS parameters dis- played high inter-observer reproducibility (κ: coefficients of 0.87 for MTT and 0.90 TTP). When the region of in-terest included a main hepatic vein, Qontrast-calculated TTP was significantly shorter in cirrhotic patients (vs non-cirrhotics and healthy subjects) (71.0 ± 11.3 s vs 82.4±15.6 s, 86.3±20.3 s, P 〈 0.05). MTIs in the patients with liver cirrhosis were significantly shorter than those of controls (111.9±22.0 s vs 139.4±39.8 s, P 〈 0.05), but there was no significant difference between the cirrhotic and non-cirrhotic groups (111.9± 22.0 s vs 110.3 ±14.6 s). Peak enhancement in the patients with liver cirrhosis was also higher than that observed in controls (23.9± 5.9 vs 18.9±7.1, P = 0.05). There were no significant intergroup differences in the RBVs and RBFs. CONCLUSION: Qontrast-assisted CEUS revealed re- producible differences in liver perfusion parameters during the development of hepatic fibrogenesis. |
---|---|
Bibliography: | Contrast enhanced ultrasound; Cirrhosis;Hepatitis; Liver perfusion; Hepatic microcirculation AIM: To assess if software assisted-contrast-enhanced ultrasonography (CEUS) provides reproducible perfu- sion parameters of hepatic parenchyma in patients af- fected by chronic liver disease. METHODS: Forty patients with chronic viral liver dis- ease, with (n = 20) or without (n = 20) cirrhosis, and 10 healthy subjects underwent CEUS and video re- cordings of each examination were then analysed with Esaote's Qontrast software. CEUS dedicated software Qontrast was used to determine peak (the maximum signal intensity), time to peak (TTP), region of blood value (RBV) proportional to the area under the time- intensity curve, mean transit time (MTT) measured in seconds and region of blood flow (RBF). RESULTS: Qontrast-assisted CEUS parameters dis- played high inter-observer reproducibility (κ: coefficients of 0.87 for MTT and 0.90 TTP). When the region of in-terest included a main hepatic vein, Qontrast-calculated TTP was significantly shorter in cirrhotic patients (vs non-cirrhotics and healthy subjects) (71.0 ± 11.3 s vs 82.4±15.6 s, 86.3±20.3 s, P 〈 0.05). MTIs in the patients with liver cirrhosis were significantly shorter than those of controls (111.9±22.0 s vs 139.4±39.8 s, P 〈 0.05), but there was no significant difference between the cirrhotic and non-cirrhotic groups (111.9± 22.0 s vs 110.3 ±14.6 s). Peak enhancement in the patients with liver cirrhosis was also higher than that observed in controls (23.9± 5.9 vs 18.9±7.1, P = 0.05). There were no significant intergroup differences in the RBVs and RBFs. CONCLUSION: Qontrast-assisted CEUS revealed re- producible differences in liver perfusion parameters during the development of hepatic fibrogenesis. 14-1219/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Francesco Ridolfi, MD, PhD, Division of Gastroenterology, Principe di Piemonte Hospital, Via Cellini 1, 60019 Senigallia, AN, Italy. francescoridolfi71@gmail.com Author contributions: Ridolfi F and Abbattista T designed the study, performed the examinations and wrote the manuscript; and Busilacchi P and Brunelli E provided the analytical tools and edited the manuscript. Telephone: +39-71-79092606 Fax: +39-71-79092604 |
ISSN: | 1007-9327 2219-2840 2219-2840 |
DOI: | 10.3748/wjg.v18.i37.5225 |